Cryptococcus neoformans infection in France: Epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus

被引:53
作者
DarrasJoly, C
Chevret, S
Wolff, M
Matheron, S
Longuet, P
Casalino, E
Joly, V
Chochillon, C
Bedos, JP
机构
[1] GRP HOSP BICHAT CLAUDE BERNARD,DEPT MALAD INFECT,SERV REANIMAT MALAD INFECT,PARIS,FRANCE
[2] GRP HOSP BICHAT CLAUDE BERNARD,DEPT MALAD INFECT,SERV MED INTERNE,PARIS,FRANCE
[3] GRP HOSP BICHAT CLAUDE BERNARD,DEPT MALAD INFECT,SERV MYCOL & PARASITOL,PARIS,FRANCE
[4] HOP ST LOUIS,DEPT BIOSTAT & MED INFORMAT,PARIS,FRANCE
关键词
D O I
10.1093/clinids/23.2.369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We retrospectively carried out a descriptive and prognostic study of 76 human immunodeficiency virus-infected patients with cryptococcosis diagnosed by a positive culture of cerebrospinal fluid (CSF), blood, urine, or other body fluid or tissue. We focused on the 65 patients with cryptococcal meningitis, At diagnosis, the mean CD4 lymphocyte count was 46/mm(3); 86% of patients had fever; 67%, headache; 37%, stiff neck; 29%, altered mentation or confusion; 20% cranial nerve deficiency; and 48%, other focal deficiencies. Analysis of CSF specimens revealed the following results: normal (25% of the specimens), leukocyte count of <20/mm(3) (62%), positive India ink smear (87%), and positive cryptococcal antigen (92%). Twenty patients died within the first 3 months (3-month survival rate, 70%), A Cox regression model selected the following as prognostic parameters: age older than 30 years (relative risk [RR] = 2.1), CSF glucose level of <2 mmol/L (RR = 3.7), previous admission to an intensive care unit (RR = 4.7), and mechanical ventilation (RR = 4.6). The outcome of cryptococcal meningitis in patients with AIDS remains difficult to predict at admission, and every case should be considered as potentially severe.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 26 条
[21]   COMPARISON OF AMPHOTERICIN-B WITH FLUCONAZOLE IN THE TREATMENT OF ACUTE AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS [J].
SAAG, MS ;
POWDERLY, WG ;
CLOUD, GA ;
ROBINSON, P ;
GRIECO, MH ;
SHARKEY, PK ;
THOMPSON, SE ;
SUGAR, AM ;
TUAZON, CU ;
FISHER, JF ;
HYSLOP, N ;
JACOBSON, JM ;
HAFNER, R ;
DISMUKES, WE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (02) :83-89
[22]  
STANSELL JD, 1993, MED MANAGEMENT AIDS, P297
[23]  
VANDERHORST C, 1994, 35 INT C ANT AG CHEM, P244
[24]   CRYPTOCOCCAL MENINGITIS - OUTCOME IN PATIENTS WITH AIDS AND PATIENTS WITH NEOPLASTIC DISEASE [J].
WHITE, M ;
CIRRINCIONE, C ;
BLEVINS, A ;
ARMSTRONG, D .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :960-963
[25]   CRYPTOCOCCAL DISEASE IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - DIAGNOSTIC FEATURES AND OUTCOME OF TREATMENT [J].
ZUGER, A ;
LOUIE, E ;
HOLZMAN, RS ;
SIMBERKOFF, MS ;
RAHAL, JJ .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (02) :234-240
[26]  
1995, B EPIDEMIOLOGIQUE HE, V22, P97